BRIEF published on 02/28/2025 at 07:35, 9 months 19 days ago ABIONYX strengthens its commitment against LCAT Deficiency Rare Disease Marketing Authorization LCAT Deficiency Biomedicine Norum Disease
PRESS RELEASE published on 02/28/2025 at 07:30, 9 months 19 days ago Informations privilégiées / Autres communiqués ABIONYX s’engage dans la Déficience LCAT (Maladie de Norum) en soutenant les patients et préparant l'AMM, bénéficiant de la Désignation de Maladie Orpheline en Europe et aux USA ABIONYX EMA Déficience LCAT Maladie De Norum Désignation Orpheline
PRESS RELEASE published on 02/28/2025 at 07:30, 9 months 19 days ago Inside Information / Other news releases ABIONYX renews commitment to treat LCAT Deficiency (Norum's disease) and provides updates on advances, including submission of Marketing Authorization Application and Orphan Disease Designation ABIONYX LCAT Deficiency Rare Disease Day Marketing Authorization Application Orphan Disease Designation
BRIEF published on 02/27/2025 at 19:25, 9 months 19 days ago ABIONYX Pharma Reports Stable Revenue and Cash Position for 2024 2024 Financial Results Innovative Therapies ABIONYX Pharma Compassionate Access CRO Industry
BRIEF published on 02/27/2025 at 19:25, 9 months 19 days ago ABIONYX Pharma annonce un chiffre d'affaires et une situation de trésorerie stables pour 2024 Résultats Financiers 2024 ABIONYX Pharma Thérapies Innovantes Accès Compassionnel Industrie Des CRO
PRESS RELEASE published on 02/27/2025 at 19:20, 9 months 19 days ago Inside Information / Information on annual revenues ABIONYX Pharma reports €4.6m revenue and €3.2m cash at the end of Q4 2024. Details on business activities and financial performance included Revenue Cash Position Financial Update Biopharma ABIONYX Pharma
PRESS RELEASE published on 02/27/2025 at 19:20, 9 months 19 days ago Informations privilégiées / Information sur chiffre d’affaires annuel ABIONYX Pharma annonce un chiffre d'affaires consolidé de 4,6M€ et une trésorerie de 3,2M€ au 31 décembre 2024 Chiffre D'affaires Trésorerie Biopharma ABIONYX Pharma Thérapies Innovantes
BRIEF published on 02/20/2025 at 07:35, 9 months 27 days ago ABIONYX Pharma reçoit un soutien de 8,7 millions d'euros pour son projet sur le sepsis France 2030 ABIONYX Pharma Sepsis Soutien Financier Biomédicament
BRIEF published on 02/20/2025 at 07:35, 9 months 27 days ago ABIONYX Pharma receives €8.7 million in support for its sepsis project Financial Support France 2030 ABIONYX Pharma Sepsis Biomedicine
PRESS RELEASE published on 02/20/2025 at 07:30, 9 months 27 days ago Informations privilégiées / Autres communiqués ABIONYX Pharma reçoit 8,7 M€ de soutien de l’Etat pour combattre le sepsis, 3ème cause de décès mondiale, grâce à son biomédicament CER-001 France 2030 ABIONYX Pharma Sepsis Soutien Financier Biomédicament
Published on 12/19/2025 at 14:40, 13 minutes ago Northern Superior Announces Closing of the Arrangement
Published on 12/19/2025 at 13:30, 1 hour 23 minutes ago Quartz Commences Trading On The OTCQX Best Market Under The Symbol QZMRF
Published on 12/19/2025 at 13:30, 1 hour 23 minutes ago DataMetrex Announces Closing of Yuzu Payment Processing Solution Acquisition
Published on 12/19/2025 at 13:30, 1 hour 23 minutes ago Sterling Metals Provides Year End Update to Stakeholders
Published on 12/19/2025 at 13:05, 1 hour 48 minutes ago Roxmore Resources Begins Trading on the OTCQX Best Market in the United States
Published on 12/19/2025 at 14:39, 13 minutes ago EQS-Adhoc: Cantourage Group SE expects EBITDA for 2025 to exceed current market expectations based on preliminary figures
Published on 12/19/2025 at 14:05, 48 minutes ago ETHGas Debuts Ethereum's Blockspace Futures Market with $800m of Commitments and $12m Seed Round Led by Polychain Capital
Published on 12/19/2025 at 14:00, 53 minutes ago EQS-Adhoc: EVAN Group plc: Delisting of Bond has been resolved
Published on 12/19/2025 at 13:31, 1 hour 22 minutes ago North Peak Confirms Historic Waste Rock Pile Mineralisation with Sonic Drilling and Completion of 2025 Reverse Circulation Exploration Drilling Program at Prospect Mountain, Nevada
Published on 12/19/2025 at 13:18, 1 hour 35 minutes ago Gennaker offshore wind farm obtains construction and operations permit
Published on 12/19/2025 at 08:30, 6 hours 23 minutes ago Share capital decrease by way of treasury shares cancellation
Published on 12/19/2025 at 08:30, 6 hours 23 minutes ago Réduction du capital par voie d’annulation d’actions propres
Published on 12/19/2025 at 07:00, 7 hours 53 minutes ago EURAZEO ANNONCE AVOIR MENÉ AVEC SUCCÈS UNE TRANSACTION ACCÉLÉRANT SA ROTATION D'ACTIFS
Published on 12/19/2025 at 07:00, 7 hours 53 minutes ago EURAZEO ANNOUNCES A SUCCESSFUL TRANSACTION ACCELERATING ITS ASSET ROTATION
Published on 12/18/2025 at 18:30, 20 hours 23 minutes ago Schneider Electric completes transaction to acquire remaining 35% stake in existing Indian JV
